Kernal Biologics Competitors and Similar CompaniesClear all

Kernal Biologics's competitors and similar companies include Legend Biotech, Mersana Therapeutics, Seagen and Dendreon.

	Kernal Biologics Kernal Biologics is a biotech company that creates mRNA therapies.	Legend Biotech Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.	Mersana Therapeutics Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms.	Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.	Dendreon Dendreon Pharmaceuticals (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy.
Founding Date	Founding Date 2016	Founding Date 2014	Founding Date 2005	Founding Date 1998	Founding Date 1992
Type	Type Private	Type Public	Type Public	Type Subsidiary	Type Subsidiary
Tags	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy
Locations	Locations Cambridge, US HQ	Locations Somerset, US HQ Ghent, BE Nanjing, CN Hong Kong, HK Dublin, IE Piscataway, US	Locations Cambridge, US HQ	Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more	Locations Seal Beach, US HQ Seattle, US Union City, US Tampa, US
Employees	Employees 15	Employees 2,90012% increase	Employees 11033% increase	Employees 3,25622% increase	Employees 6131% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) 8.4 b	Valuation ($) 250.3 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $1b (FY, 2025)	Revenue (est.) $40.5m (FY, 2024)	Revenue (est.) $2b (FY, 2022)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $408.1m (FY, 2025)	Cost of goods N/A	Cost of goods $410.1m (FY, 2022)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $620.8m (FY, 2025)	Gross profit N/A	Gross profit $1.6b (FY, 2022)	Gross profit N/A
Net income	Net income N/A	Net income ($296.8m) (FY, 2025)	Net income ($69.2m) (FY, 2024)	Net income ($610.3m) (FY, 2022)	Net income N/A
Funding
Total funding raised	Total funding raised $ 25.5m	Total funding raised $ 150.5m	Total funding raised $ 219.5m	Total funding raised $ 164m	Total funding raised N/A